Eikon Therapeutics, Inc.
EIKN
$10.73
$0.020.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -6.57% | -4.15% | -54.17% | ||
| Total Depreciation and Amortization | -1.63% | 2.14% | -2.44% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 103.30% | -42.34% | 1,408.18% | ||
| Change in Net Operating Assets | 204.72% | -146.95% | 624.37% | ||
| Cash from Operations | 27.66% | -115.23% | 39.96% | ||
| Capital Expenditure | 4.20% | -296.97% | 2.87% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 123.00% | -597.73% | 92.61% | ||
| Cash from Investing | 122.85% | -599.18% | 83.22% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -99.99% | 31,976.03% | 2,419.05% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -99.99% | 31,976.03% | -99.85% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -132.87% | 74,953.33% | -183.18% | ||